News
12h
Zacks Investment Research on MSNQuest Diagnostics Beats Q2 Earnings & Revenue Estimates, Stock RisesQuest Diagnostics Inc.’s DGX second-quarter 2025 adjusted earnings per share (EPS) of $2.62 beat the Zacks Consensus Estimate by 1.9%. The metric also exceeded the year-ago adjusted figure by 11.5%.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results